share_log

Mizuho Downgrades Athira Pharma to Neutral, Lowers Price Target to $0.5

Benzinga ·  Sep 19 18:51  · Ratings

Mizuho analyst Graig Suvannavejh downgrades Athira Pharma (NASDAQ:ATHA) from Outperform to Neutral and lowers the price target from $5 to $0.5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment